UnitedHealth beats expectations, raises outlook as turnaround gains momentum

UnitedHealth Group turned in a better-than-expected first quarter and raised its 2026 profit outlook, but the numbers suggested a company still grinding through a slow and uneven recovery rather than staging a clean rebound. The nation’s largest insurer reported adjusted earnings of $7.23 a share on revenue of $111.7 billion, and said full-year adjusted earnings should now exceed $18.25 a share, up from its January forecast of more than $17.75.

The quarter marked only modest top-line growth, with revenue up 2% from a year earlier. Operating earnings came to $9.0 billion, while net margin held at 5.6%, just below 5.7% in the first quarter of 2025. The company’s medical cost ratio, a closely watched measure of how much premium income is spent on patient care, was 83.9%, down 90 basis points from a year ago. Cash flow from operations reached $8.9 billion, or 1.4 times net income, a sign that UnitedHealth is still generating strong cash even as it works through industry-wide cost pressure.

Stephen Hemsley said the quarter unfolded largely as expected and that all major business segments exceeded plan. Investors responded positively, sending the shares higher in premarket trading. Still, the results underscored how much room UnitedHealth has left to rebuild momentum after a difficult 2025, when the company posted revenue of $447.6 billion and adjusted earnings of $16.35 a share.

The broader significance reaches well beyond one insurer’s quarterly beat. Health insurers have been under strain from higher medical utilization, particularly in government-backed Medicare plans, where patients are using more care and margins have been harder to protect. UnitedHealth said improved government payments helped its health insurance business, a reminder that pricing power and reimbursement policy now matter as much as enrollment growth. UnitedHealthcare also said pricing is improving relative to elevated health care cost trends and that affordability initiatives are gaining momentum, but the quarter’s narrow margin improvement showed how fragile that progress remains.

UnitedHealth has spent several quarters trying to reset its business, refocusing on U.S. health care, exiting non-U.S. operations and refreshing nearly half of its top 100 leadership roles. The first-quarter figures suggested those changes are helping stabilize performance, but they did not erase the underlying pressures facing the industry. For investors and patients alike, the next test will be whether cost trends, Medicare Advantage scrutiny and government payment support keep moving in UnitedHealth’s favor, or whether the insurer’s recovery slows again under the weight of a tougher care environment.